在代谢性疾病中,葡萄糖类1和肠道微生物群之间的交叉关系
Yuan Zeng1, Yifan Wu1, Qian Zhang1
1Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
mBio
|December 6, 2023
概括
肠道微生物群影响葡萄糖类1 (GLP-1) 的分泌和功能,影响肥胖和2型糖尿病等代谢疾病. 针对肠道微生物群的干预措施可以提供个性化的治疗策略.
科学领域:
- 微生物学 微生物学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 肠道微生物群调节关键的生理过程,包括消化,新陈代谢和免疫功能.
- 类似葡萄糖的1 (GLP-1),一种内激素,对葡萄糖稳定至关重要,并在肠道中产生.
- 肠道微生物组成和功能的改变与代谢障碍有关,如肥胖和2型糖尿病 (T2D).
研究的目的:
- 在代谢疾病的背景下,审查肠道微生物群和GLP-1信号传递之间的复杂关系.
- 阐明肠道微生物群代谢物如何影响GLP-1分泌,功能和节律.
- 讨论干预措施对肠道微生物群的影响-GLP-1轴.
主要方法:
- 文献综述综合了关于肠道微生物群和GLP-1相互作用的当前研究.
- 分析微生物对GLP-1分泌和功能影响的机制.
- 在这个轴上检查干预效应 (益生菌,益生菌,药物,手术).
主要成果:
- 肠道微生物群的代谢物直接刺激GLP-1分泌,调节其生理节奏和功能.
- GLP-1对肠道微生物群产生影响,部分是通过调节炎症反应.
- 诸如益生菌,益生菌,抗糖尿病药物和减肥手术等干预措施显示出改变肠道微生物群-GLP-1轴的能力.
结论:
- 肠道微生物群是管理代谢性疾病的重要治疗点.
- 考虑到肠道微生物组,GLP-1受体激动剂的个性化临床应用是有必要的.
相关概念视频
Glucagon-like Receptor Agonists
329
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
329
What is Monogastric Digestion?
71.2K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Hypoglycemia and Glucagon
272
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
272
Overview of Carbohydrate Metabolism
1.1K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.1K
Glucose Absorption Into the Small Intestine
31.7K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.7K


